Harmonicare Medical : CLARIFICATION ANNOUNCEMENT

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 1509)

CLARIFICATION ANNOUNCEMENT

Reference is made to the announcement of Harmonicare Medical Holdings Limited (the "Company") dated 19 February 2021 in relation to the Disclosable Transaction - Disposal of 51% Equity Interests in the Target Company (the "Announcement"). Capitalised terms used in this announcement shall have the same meaning as those defined in the Announcement, unless otherwise stated therein.

The Board noted a clerical error in the Announcement and would like to clarify that the net assets value of the Target Company as of 31 December 2019 extracted from its unaudited management accounts for the financial year ended 31 December 2019 as shown in "Part III - Information on the Target Company" should be 153,188 instead of (153,188).

Save as disclosed herein, all the information in the Announcement remains unchanged.

CONTINUED SUSPENSION OF TRADING

At the request of the Company, trading in the shares of the Company on the Stock Exchange has been suspended with effect from 9:00 a.m. on 1 April 2019. Trading in the Shares will remain suspended until further notice.

Shareholders and potential investors are advised to exercise caution when dealing in the securities of the Company.

By Order of the Board

Harmonicare Medical Holdings Limited

Lin Yuming

Chairman, Executive Director and President

Hong Kong, 24 February 2021

As at the date of this announcement, the executive Directors are Mr. Lin Yuming, Mr. Yang Guo and Mr. Wei Rongda and Mr. Chen Longzhen; the non-executive Directors are Mr. Qiu Jianwei and Mr. Xu Jun; and the independent non-executive Directors are Ms. Hsu Wai Man Helen, Mr. Zhang Jide and Mr. Lin Jinting.